SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 10, 2004
HEMAGEN DIAGNOSTICS, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 1-11700 | 04-2869857 |
|---|
(State or other jurisdiction
of incorporation) | (Commission File No.) | (IRS Employer
Identification No.) |
9033 Red Branch Road, Columbia, Maryland 21045
(Address of principal executive offices) (Zip Code)
(410) 740-3198
(Registrant’s telephone number, including area code)
Item 5 – Other Events and Required FD Disclosure.
The Registrant issued the press releases attached as Exhibit 99.1 and 99.2 on March 10 and 11, 2004, respectively.
Item 7. – Financial Statements, Pro Forma Financial Information and Exhibits.
| | Exhibit 99.1 – Press Release dated March 10, 2004
Exhibit 99.2 – Press Release dated March 11, 2004 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: March 16, 2004 | | HEMAGEN DIAGNOSTICS, INC.
By: /s/Deborah F. Ricci
——————————————
Deborah F. Ricci
Chief Financial Officer
(Principal Accounting Officer) |
